SEC Form 4/A · accession 0001209191-15-087456
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Stephen R. La Neve
Officer — CEO and President · Director
Period of report
Aug 17, 2015
Accepted (ET)
Dec 31, 2015 · 11:01 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.58 | Aug 17, 2015 | J | 2,081,191 | D | — | — | Common Stock | 2,081,191 | 0 | D |
Explanation of responses
- F1This Form 4 Amendment is being filed to report that the option grant reported on Form 4 filed with the Securities and Exchange Commission on August 19, 2015 was granted under an equity incentive plan that never became effective and, as a result, the option was never validly issued.